Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1471
https://www.valueinhealthjournal.com/article/S1098-3015(16)32837-6/fulltext
Title :
Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32837-6&doi=10.1016/j.jval.2016.09.1471
First page :
A602
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1384